Kiniksa Pharmaceuticals International, plc (KNSA)

KNSA Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	73.06	59.01	-43.19	14.08	183.36	-157.92
Depreciation & Amortization	1.68	1.55	1.7	2.34	2.4	2.36
Stock-Based Compensation	39.31	37	30.69	27.15	25.12	25.17
Other Adjustments	18.3	15.63	11.69	2.17	-182.5	3.41
Change in Receivables	-12	-2.71	26.13	-20.46	-8.68	-3.91
Changes in Inventories	-51.07	-28.53	4.76	-9.52	-17.92	-3.68
Changes in Accounts Payable	22.35	0.14	-6.31	0.35	6.03	1.37
Changes in Accrued Expenses	36.05	37.5	43.73	16.94	-3.71	10.34
Changes in Unearned Revenue	19.55	19.55	0.26	16.7	12	-
Changes in Other Operating Activities	-12.9	-25.04	-27.51	-26.37	-10.3	-3.43
Operating Cash Flow	165.86	137.99	25.69	13.3	5.81	-126.3
Operating Cash Flow Growth	276.73%	437.14%	93.14%	129.05%	-	-
Capital Expenditures	-1.63	-1.57	-0.28	-0.13	-0.11	-0.42
Sale of Property, Plant & Equipment	-	-	0.03	-	0.09	-
Purchases of Intangible Assets	-	-	-	-	-	-20
Purchases of Investments	-468.86	-386.92	-202.01	-204.93	-135.86	-157.25
Proceeds from Sale of Investments	301.12	199.49	239.94	175.51	127.8	306.3
Investing Cash Flow	-169.37	-188.99	37.67	-29.56	-8.08	128.64
Issuance of Common Stock	43.96	40.75	17.25	3.7	3.42	5.89
Repurchase of Common Stock	-7.63	-7.73	-4.98	-2.21	-0.9	-
Net Common Stock Issued (Repurchased)	36.33	33.02	12.27	1.5	2.52	5.89
Financing Cash Flow	36.33	33.02	12.27	1.5	2.52	5.89
Net Cash Flow	32.82	-17.99	75.63	-14.76	0.25	8.22
Free Cash Flow	164.23	136.42	25.41	13.17	5.7	-126.71
Free Cash Flow Growth	20.39%	436.82%	92.94%	130.99%	-	-
FCF Margin	21.78%	20.13%	6.00%	4.87%	2.59%	-328.75%
Free Cash Flow Per Share	2.04	1.73	0.36	0.18	0.08	-1.85
Levered Free Cash Flow	87.08	62.61	-26.85	14.39	171.76	-151.39
Unlevered Free Cash Flow	136.19	106.78	-20.39	-71.4	-154.58	-148.71

Updated Apr 28, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q